Company / AR per Share
BeOne Medicines Ltd. AR per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.62
FY2025
5-year range
$0.13 / $0.62
FY2021-FY2025
Trend
+25.3%
vs FY2024
Sector context
#61 of 115
Health Care
What the data says
At $0.62, BeOne Medicines Ltd.'s ar per share ranks #61 of 115 in the Health Care sector. AR per Share has increased for 3 consecutive years, from $0.13 in FY2022 to $0.62 in FY2025.
Based on SEC 10-K filings.
0.62 in FY2025 with a 5-year CAGR of +52.6%.
Improved from $0.26 to $0.62 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +68.8%
- 5-Year CAGR
- +52.6%
- 10-Year CAGR
- -
Sector benchmark
#61 of 115 in Health CareTop 53% of 115This company $0.62 Sector average $27.05
▼
-97.7% below sector average
Key checks
Key Insights
- BeOne Medicines Ltd.'s ar per share has grown for 3 consecutive years.
- In FY2025, ar per share increased 25.3% year-over-year.
- Ranks #61 out of 115 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.82 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.62 | +25.3% |
| FY2024 | $0.50 | +88.4% |
| FY2023 | $0.26 | +103.5% |
| FY2022 | $0.13 | -67.6% |
| FY2021 | $0.40 | +431.4% |
| FY2020 | $0.08 | -17.4% |
| FY2019 | $0.09 | +31.7% |
| FY2018 | $0.07 | +21.5% |
| FY2017 | $0.06 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026